Table 3.
Comparison of antibiotic resistance rates of Acinetobacter baumannii strains isolated from ETA cultures of pre-pandemic ICU and pandemic-period Covid-19 ICU patients.
| Pre-pandemic ICU |
Covid-19 ICU |
Total |
p | ||||
|---|---|---|---|---|---|---|---|
| S | R | S | R | S | R | ||
| AK | 19 (55.9) | 15 (44.1) | 17 (36.2) | 30 (63.8) | 36 (44.4) | 45 (55.6) | 0.125 |
| GN | 4 (14.3) | 24 (85.7) | 2 (4.3) | 45 (95.7) | 6 (8) | 69 (92) | 0.188 |
| COL | 33 (100) | 0 (0) | 47 (100) | 0 (0) | 80 (100) | 0 (0) | x |
| MEM | 0 (0) | 34 (100) | 0 (0) | 46 (100) | 0 (0) | 80 (100) | x |
| TPZ | 0 (0) | 17 (100) | 0 (0) | 46 (100) | 0 (0) | 63 (100) | x |
| NET | 2 (6.3) | 30 (93.8) | 0 (0) | 44 (100) | 2 (2.6) | 74 (97.4) | 0.174 |
| CİP | 0 (0) | 33 (100) | 0 (0) | 47 (100) | 0 (0) | 80 (100) | x |
| LEV | 0 (0) | 34 (100) | 0 (0) | 41 (100) | 0 (0) | 75 (100) | x |
| IMP | 0 (0) | 17 (100) | 0 (0) | 41 (100) | 0 (0) | 58 (100) | x |
| TGC | 28 (82.4) | 6 (17.6) | 45 (97.8) | 1 (2.2) | 73 (91.3) | 7 (8.8) | 0.038* |
| TOB | 6 (18.8) | 26 (81.3) | 1 (2.3) | 42 (97.7) | 7 (9.3) | 68 (90.7) | 0.037* |
| SXT | 19 (55.9) | 15 (44.1) | 25 (53.2) | 22 (46.8) | 44 (54.3) | 37 (45.7) | 0.989 |
*p < 0.05 significant relationship, p > 0.05 no significant relationship; Chi-square test – x:Test not possible.
AK: amikacin, GN: gentamicin, COL: colistin, MEM: meropenem, TPZ: piperacillin tazobactam, NET: netilmicin, CIP: ciprofloxacin, LEV: levofloxacin, IMP: imipenem, TGC: tigecycline, TOB: tobramycin, SXT: trimethoprim sulfamethoxazole.